Approved Formulary
QR Code Add Formweb to your mobile device
February P&T meeting minutes have been posted.
Approved Formulary
Search results for:

norethindrone-ethinyl estradiol-fe

norethindrone-ethinyl estradiol-fe
  • Hazardous Drugs Handling Guide (Group 2: Non-Antineoplastic)
  • Cell Status In
  • Exceptions / Designators Formulary restricted 1/20 and 1.5/30 combinations. Available as norethindrone 1.5 mg with ethinyl estradiol 30 mcg packaged as 21 active tablets and 7 iron tablets as placebo or norethindrone 1 mg with ethinyl estradiol 20 mcg.
Brand names: AUROVELA FE 1.5/30, BLISOVI FE 1.5/30, BLISOVI FE 1/20, HAILEY FE 1.5/30, JUNEL FE 1.5/30, JUNEL FE 1/20, LOESTRIN FE 1.5/30, MIBELAS 24 FE, MICROGESTIN 24 FE, MICROGESTIN FE 1.5/30, TARINA FE 1/20
Form Strength  
TABLET, ORAL 1 mg-20 mcg; 1.5 mg-30 mcg

Additional Information:

MAY 2022 P&T MINUTES


Last updated: Nov. 16, 2023
  • In-Cell HD


This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.